• Transcept Pharmaceuticals Inc., of Point Richmond, Calif., recorded about $500,000 in royalty revenue from sales of insomnia drug Intermezzo (low-dose zolpidem) generated by partner Purdue Pharma LP, of Stamford, Conn.